Monitoring response and resistance to the novel arsenical Darinaparsin in an AML patient
Tribl F, Gerlach M, Marcus K, Asan E, Tatschner T, Arzberger T, Meyer HE, Bringmann G, Riederer P: "Subcellular proteomics" of neuromelanin granules isolated from the human brain
If a medication is used off-label, an important consideration is that most private insurance plans will not cover the cost, and patients should be prepared for out-of-pocket expenses
The body does not develop true pharmacological tolerance to Retatrutide in the way it might with stimulant-based weight loss compounds
Clin Chim Acta 275 : 175184 Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG 1986 Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution
We recommend contacting your insurance provider to determine your eligibility